Published with this product (43)
2024British Journal of Pharmacology, 1-17
Flavia T. T. Antunes, Maria A. Gandini, Vinicius M. Gadotti, Nara Lins Meira Quintao, José Roberto Santin, Ivana A. Souza, Laurence S. David, Terrance P. Snutch, Michael Hildebrand, and Gerald W. Zamponi
doi:10.1111/bph.173372024Medicina, 60(6), 989
Chae-Chil Lee, Ki-Bong Park, Min Seok Kim, and Young Dae Jeon
doi:10.3390/medicina600609892024Translational Psychiatry, 14:197
John Peyton Bohnsack, Huaibo Zhang, and Subhash C. Pandey
doi:10.1038/s41398-024-02906-y2022Molecular Pain, 18:17448069221107781
Dylan W Maixner, David Christy, Lingwei Kong, Viacheslav Viatchenko-Karpinski, Kristen A Horner, Shelley B Hooks, and Han-Rong Weng
doi:10.1177/174480692211077812022Molecular Psychiatry
Unraveling the Epigenomic and Transcriptomic Interplay During Alcohol-Induced Anxiolysis
Harish R. Krishnan, Huaibo Zhang, Ying Chen, John Peyton Bohnsack, Annie W. Shieh, Handojo Kusumo, Jenny Drnevich, Chunyu Liu, Dennis R. Grayson, Mark Maienschein-Cline, and Subhash C. Pandey
doi:10.1038/s41380-022-01732-2
Description
i-FectTM is a novel cationic lipid formulation specifically designed for efficient delivery of siRNAs (small interfering RNAs) into a wide variety of cell types. Customers have been using i-Fect for both in vitro and in vivo applications.
Kit Contents
-
Hydrated i-Fect ™ Lipid
-
siRNA Diluent
Product Highlights:
Related products
For research use only. Not for diagnostic or clinical use.
